60
Participants
Start Date
January 31, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
December 31, 2015
Pirfenidone with MODD
Patients with diabetic foot ulcer will be treated three times a day with a smooth layer (standar finger tip unit 0.5g for an area of 100 to 120 square centimeters) of KitosCell Q (Pirfenidone with MODD) in form of gel and the wound will be covered with a bandage.
Ketanserin
Patients will be administered ketanserin twice a day usign the standar finger tip unit (0.5g for an area of 100 to 120 square centimeters) and the wound will be covered with a bandage. This arm is a control for evolution of diabetic foot ulcer.
Molecular Biology and Gene Therapy Institute, Guadalajara
Hospital Valentín Gómez Farías, Zapopan
Collaborators (1)
Cell Pharma
OTHER
University of Guadalajara
OTHER